Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study
Titel:
Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study
Auteur:
Melichar, Bohuslav Adenis, Antoine Lockhart, A Craig Bennouna, Jaafar Dees, E Claire Kayaleh, Omar Obermannova, Radka DeMichele, Angela Zatloukal, Petr Zhang, Bin Ullmann, Claudio Dansky Schusterbauer, Claudia